Literature DB >> 15037085

Allosteric inhibition through core disruption.

James R Horn1, Brian K Shoichet.   

Abstract

Although inhibitors typically bind pre-formed sites on proteins, it is theoretically possible to inhibit by disrupting the folded structure of a protein or, in the limit, to bind preferentially to the unfolded state. Equilibria defining how such molecules act are well understood, but structural models for such binding are unknown. Two novel inhibitors of beta-lactamase were found to destabilize the enzyme at high temperatures, but at lower temperatures showed no preference for destabilized mutant enzymes versus stabilized mutants. X-ray crystal structures showed that both inhibitors bound to a cryptic site in beta-lactamase, which the inhibitors themselves created by forcing apart helixes 11 and 12. This opened up a portion of the hydrophobic core of the protein, into which these two inhibitors bind. Although this binding site is 16 A from the center of the active site, the conformational changes were transmitted through a sequence of linked motions to a key catalytic residue, Arg244, which in the complex adopts conformations very different from those in catalytically competent enzyme conformations. These structures offer a detailed view of what has heretofore been a theoretical construct, and suggest the possibility for further design against this novel site.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037085     DOI: 10.1016/j.jmb.2003.12.068

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  34 in total

1.  Equilibrium fluctuations of a single folded protein reveal a multitude of potential cryptic allosteric sites.

Authors:  Gregory R Bowman; Phillip L Geissler
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

Review 2.  Antibody-enabled small-molecule drug discovery.

Authors:  Alastair D G Lawson
Journal:  Nat Rev Drug Discov       Date:  2012-06-29       Impact factor: 84.694

Review 3.  Virtual screening of chemical libraries.

Authors:  Brian K Shoichet
Journal:  Nature       Date:  2004-12-16       Impact factor: 49.962

4.  Active TEM-1 beta-lactamase mutants with random peptides inserted in three contiguous surface loops.

Authors:  Pascale Mathonet; Julie Deherve; Patrice Soumillion; Jacques Fastrez
Journal:  Protein Sci       Date:  2006-09-08       Impact factor: 6.725

5.  Discovery of multiple hidden allosteric sites by combining Markov state models and experiments.

Authors:  Gregory R Bowman; Eric R Bolin; Kathryn M Hart; Brendan C Maguire; Susan Marqusee
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-17       Impact factor: 11.205

Review 6.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

7.  Exploring the structural origins of cryptic sites on proteins.

Authors:  Dmitri Beglov; David R Hall; Amanda E Wakefield; Lingqi Luo; Karen N Allen; Dima Kozakov; Adrian Whitty; Sandor Vajda
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

Review 8.  Advanced Methods for Accessing Protein Shape-Shifting Present New Therapeutic Opportunities.

Authors:  Catherine R Knoverek; Gaya K Amarasinghe; Gregory R Bowman
Journal:  Trends Biochem Sci       Date:  2018-12-14       Impact factor: 13.807

9.  Impact of mutations on the allosteric conformational equilibrium.

Authors:  Patrick Weinkam; Yao Chi Chen; Jaume Pons; Andrej Sali
Journal:  J Mol Biol       Date:  2012-12-07       Impact factor: 5.469

Review 10.  Docking screens: right for the right reasons?

Authors:  Peter Kolb; John J Irwin
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.